NCT00210301View on ClinicalTrials.gov

Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2003

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG

Provigil (modafinil)

Trial Locations (1)

20422

RECRUITING

Veterans Affairs Medical Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Institute for Clinical Research

OTHER